Liposomial pegylate doxorubicine and trasuzumab in the first line treatment of the metastatised Her2 positive breast cancer for senior women.
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2011
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Jun 2011 New trial record